ACE2: Its Role in the Counter-Regulatory Response to Heart Failure

Renin Angiotensin System and the Heart

Volumn , Issue , 2006, Pages 119-135

  Zisman, Lawrence S ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

ACE knockout mouse; Ang (1 7) receptor; Angiotensin II (Ang II); Angiotensin metabolites; Carboxypeptidase A; Cardiac renin angiotensin system (RAS); Peptide hydrolysis site preference; Prolylendopeptidases (PEPs); Z Pro Prolinal

Indexed keywords

EID: 3242689277     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470032103.ch9     Document Type: Chapter

References (44)

1. Abbas AG, Gorelik L and Carbini SA (1997) Angiotensin-(1-7) induces bradykininmediated hypotensive responses in anesthetized rats. Hypertension 30, 217-221.
2. 1-receptor subtype in failing human ventricular myocardium. Circulation 95, 1193-1200.
3. Barton M, Shaw S, d'Uscio L, et al. (1997) Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. Biochemical and Biophysical Research Communications 238, 861-865.
4. Bernier SG, Bellemare JM, Escher E and Guillemette G (1998) Characterization of AT4 receptor from bovine aortic endothelium with photosensitive analogues of angiotensin IV. Biochemistry 37, 4280-4287.
5. 4 receptor. Endocrinology Research 24, 315-323.
6. Campbell DJ, Kladis A and Duncan AM (1994) Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23, 439-449.
7. Coleman JK, Krebs LT, Hamilton TA, et al. (1998) Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides 19, 269-277.
8. Crackower MA, Sarao R, Oudit GY, et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417, 799-802.
9. Dales NA, Gould AE, Brown JA, et al. (2002) Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. Journal of the American Chemical Society 124, 11852-11853.
10. Donoghue M, Hsieh F, Baronas E, et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circulation Research 87, E1-E9.
11. Ferrario C, Chappell M, Tallant EK, et al. (1997) Counterregulatory actions of angiotensin-(1-7). Hypertension 30, 535-541.
12. Fitzgerald SM, Evans RG, Bergstrom G and Anderson WP (1999) Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats. Journal of Cardiovascular Pharmacology 34, 206-211.
13. Freeman E, Chisolm G, Ferrario C and Tallant E (1996) Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 28, 104-108.
14. Hall KL, Venkateswaran S, Hanesworth JM, et al. (1995) Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regulatory Peptides 58, 107-115.
15. Harmer D, Gilbert M, Borman R and Clark KL (2002) Quantitative mRNA expression profiling of ACE2, a novel homologue of angiotensin converting enzyme. FEBS Letters 532(1-2), 107-110.
16. 2 angiotensin receptor gene expression in human heart failure. Circulation 95, 1201-1206.
17. Huang L, Sexton DJ, Skogerson K, et al. (2003) Novel peptide inhibitors of angiotensin-converting enzyme 2. Journal of Biological Chemistry 278, 15532-15540.
18. Iyer S, Chappell M, Averill D, et al. (1998) Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 31, 699-705.
19. Jackman HL, Massad MG, Sekosan M, et al. (2002) Angiotensins 1-9 and 1-7 release in human heart: role of cathepsin A. Hypertension 39, 976-981.
20. Johnson G, Stevenson T and Ahn K (1999) Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin. Journal of Biological Chemistry 274, 4053-4058.
21. Konstam MA, Rousseau MF, Kronenberg MW, et al. (1992) Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 86, 431-438.
22. Llorens-Cortes C, Huang H, Vicart P, et al. (1992) Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. Journal of Biological Chemistry 267, 14012-14018.
23. Morawietz H, Goettsch W, Szibor M, et al. (2002) Angiotensin-converting enzyme inhibitor therapy prevents upregulation of endothelin-converting enzyme-1 in failing human myocardium. Biochemical and Biophysical Research Communications 295, 1057-1061.
24. Moriyama A, Nakanishi M and Sasaki M (1988) Porcine muscle prolyl endopeptidase and its endogenous substrates. Journal of Biochemistry 104, 112-117.
25. Odya C, Marinkovic D, Hammon K, et al. (1978) Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. Journal of Biological Chemistry 253, 5927-5931.
26. Piedimonte G, Nadel J, Long C and Hoffman J (1994) Neutral endopeptidase in the heart: neutral endopeptidase inhibition prevents isoproterenol-induced myocardial hypoperfusion in rats by reducing bradykinin degradation. Circulation Research 75, 770-779.
27. Porsti I, Bara AT, Busse R and Hecker M (1994) Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. British Journal of Pharmacology 111, 652-654.
28. Reaux A, Iturrioz X, Vazeux G, et al. (2000) Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochemical Society Transactions 28, 435-440.
29. Sabbah HN, Sharov VG, Lesch M and Goldstein S (1995) Progression of heart failure: a role for interstitial fibrosis. Molecular and Cellular Biochemistry 147, 29-34.
30. Sadoshima J-I, Xu Y, Slayter H and Izumo S (1993) Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75, 977-984.
31. Santos RAS, Brosnihan KB, Jacobsen DW, et al. (1992) Production of angiotensin- (1-7) by human vascular endothelium. Hypertension 19, II56-II61.
32. Shirasawa Y, Osawa T and Hirashima A (1994) Molecular cloning and characterization of prolyl endopeptidase from human T cells. Journal of Biochemistry 115, 724-729.
33. Skidgel RA and Erdos EG (1998) Cellular carboxypeptidases. Immunological Reviews 161, 129-141.
34. SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine 325, 293-302.
35. Studer R, Reinecke H, Muller B, et al. (1994) Increased angiotensin-I converting enzyme gene expression in the failing human heart. Journal of Clinical Investigation 94, 301-310.
36. Tallant E, Lu X, Weiss R, et al. (1997) Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 29, 388-393.
37. Tan F, Morris P, Skidgel RA and Erdos EG (1993) Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families. Journal of Biological Chemistry 268, 16631-16638.
38. Tipnis SR, Hooper NM, Hyde R, et al. (2000) A human homolog of angiotensinconverting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry 275, 33238-33243.
39. Vickers C, Hales P, Kaushik V, et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. Journal of Biological Chemistry 277, 14838-14843.
40. Yang H, Erdos E and Chiang T (1968) New enzymatic route for the inactivation of angiotensin. Nature 218, 1224-1226.
41. Zhang H, Wada J, Hida K, et al. (2001) Collectrin, a collecting duct-specific transmembrane glycoprotein is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. Journal of Biological Chemistry 276, 17132-17139.
42. Zisman LS, Abraham WT, Meixell GE, et al. (1995) Angiotensin II formation in the intact human heart: predominance of the angiotensin converting enzyme pathway. Journal of Clinical Investigation 95, 1490-1498.
43. 1 receptor density in primary pulmonary hypertension (PPH). Circulation 98, 1735-1741.
44. Zisman LS, Keller RS, Weaver B, et al. (2003) Increased angiotensin-(1-7) forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin converting enzyme homolog, ACE2. Circulation 108, 1707-1712.